A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Janssen Research & Development, LLC
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Pfizer
Acerta Pharma BV
University of Pittsburgh
University of California, San Diego
Columbia University
Merck Sharp & Dohme LLC
Novartis
Therapeutic Advances in Childhood Leukemia Consortium
Alexion Pharmaceuticals, Inc.
Novartis
Merck Sharp & Dohme LLC
Takeda
Regeneron Pharmaceuticals
Amgen
Shanghai Junshi Bioscience Co., Ltd.
Incyte Corporation
Incyte Corporation
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Georgetown University
Istari Oncology, Inc.
Celgene
Thomas Jefferson University
Big Ten Cancer Research Consortium
Regeneron Pharmaceuticals
Dizal Pharmaceuticals
BeiGene
Children's Oncology Group
HiberCell, Inc.
Eastern Cooperative Oncology Group
Aprea Therapeutics
Aprea Therapeutics
MacroGenics
SecuraBio
Juno Therapeutics, a Subsidiary of Celgene
Pfizer
Duke University
BeiGene
Stanford University
Celgene
SWOG Cancer Research Network
AstraZeneca
Bristol-Myers Squibb
AstraZeneca
Gilead Sciences